Chronic systemic inflammation in pathways of metabolic syndrome associated with hyperandrogenism (review)

Keywords: chronic inflammation, obesity, metabolic syndrome, insulin resistance, hyperandrogenism, polycystic ovary syndrome

Abstract

This review addresses aspects of chronic systemic inflammation and its role in the pathogenesis of metabolic syndrome (MS)
associated with hyperandrogenism (HA).
The objective of this review was to systematize available data on the role of chronic systemic inflammation in the pathogenesis of metabolic complications of hyperandrogenism. Search for information was performed in the PubMed, EMBASE, Google Scholar, and E-library databases; 2000–2020 information was analyzed. The article presents the current view on chronic systemic inflammation and MS; major associations of MS and hyperandrogenism (HA) are also described. Polycystic ovary syndrome (PCOS), as well as MS, was shown to be associated with chronic systemic inflammation, insulin resistance, and obesity. However, it is not always possible to establish the causal nature of this relationship. The final part of the review summarizes information about the most significant markers of chronic systemic inflammation, which are specific for MS and HA.

Published
2020-09-03
How to Cite
Igumnov, I. A., Sharifulin, E. M., Belenkaia, L. V., Lazareva, L. M., Atalyan, A. V., Vilson, N. I., & Suturina, L. V. (2020). Chronic systemic inflammation in pathways of metabolic syndrome associated with hyperandrogenism (review). Patogenez (Pathogenesis), 18(3), 12-18. https://doi.org/10.25557/2310-0435.2020.03.12-18